Telephone Whatsapp
NABH Accredited NABL Accredited ISO Certified
NABH Accredited NABL Accredited ISO Certified
img

CA-15.3 (F010) -Delhi

Home arrow Service arrow Pathology OUTSOURCE arrow CA-15.3 (F010)-Delhi
OUTSOURCE

CA-15.3 (F010)

Also Known As: CA 15.3 CA15.3

About This Test

This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.

Test Parameters (1)

  • CA 15.3, SERUM
Home Collection
✓ Available
Reports Available In
1 Days

Frequently Asked Questions

Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.

No special preparation required

This test is important for monitoring breast cancer, evaluating treatment effectiveness, and detecting recurrence early.

TAT Policy

The Turnaround Time (TAT) depends on the following factors:

  • Registration date and time
  • Type of scan or test
  • Scan time or sample collection time

In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.

₹1,480
Home Collection
✓ Available
Reports Available In
1 Days
Get a Call Back Book Now

Have a query or suggestion for us? Feel free to drop us a message and we'll get back to you as soon as possible.